X
XENON PHARMACEUTICALS INC
NASDAQ: XENE (Xenon Pharmaceuticals Inc.)
Last update: 2 hours ago58.65
-0.15 (-0.26%)
| Previous Close | 58.80 |
| Volume | 466,752 |
| Price / Sales | 591.55 |
| Price / Book | 4.57 |
| 52 Weeks Range |
| Operating Margin (TTM) | -969.84% |
| Diluted EPS (TTM) | -3.22 |
| Total Debt/Equity (MRQ) | 1.23% |
| Current Ratio (MRQ) | 17.66 |
| Operating Cash Flow (TTM) | -196.85 M |
| Levered Free Cash Flow (TTM) | -128.49 M |
| Return on Assets (TTM) | -22.03% |
| Return on Equity (TTM) | -31.60% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Mixed | Bullish |
| Biotechnology (Global) | Mixed | Bullish | |
| Stock | Xenon Pharmaceuticals Inc. | Mixed | Bullish |
AIStockmoo Score
-1.2
| Analyst Consensus | NA |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | -5.0 |
| Technical Oscillators | -0.5 |
| Average | -1.17 |
|
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 0.14% |
| % Held by Institutions | 103.51% |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| SVORONOS DAWN | - | - | 0 | 0 |
| Aggregate Net Quantity | 0 | |||
| Aggregate Net Value ($) | 0 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| SVORONOS DAWN | Director | 01 Sep 2026 | Option execute | 5,144 | - | - |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |